Incidence of bleeding complications associated with abciximab use in conjunction with thrombolytic therapy in patients requiring percutaneous transluminal coronary angioplasty - 08/09/11
Doi : 10.1016/S0002-9149(99)00151-4
Deborah W Sundlof a : DO, Pairoj Rerkpattanapitat, MD a, Nattawut Wongpraparut, MD a, Padmavathi Pathi, MD a, Morris N Kotler, MD a, Larry E Jacobs, MD a, Gary S Ledley, MD a, Shahriar Yazdanfar, MD a, ⁎
a Division of Cardiovascular Medicine, Albert Einstein Medical Center, Philadelphia, Pennsylvania, USA
*Dr. Yazdanfar’s address is: Cardiovascular Division, Albert Einstein Medical Center, Catheterization Laboratory, Levy Ground Floor, 5501 Old York Road, Philadelphia, Pennsylvania 19141
 | This study was supported in part by the Women’s League for Medical Research, Albert Einstein Medical Center, Philadelphia, Pennsylvania. |
© 1999
Excerpta Medica Inc. Tous droits réservés.
Vol 83 - N° 11
P. 1569-1570 - juin 1999 Retour au numéro
Article précédent
- Coronary artery stent restenosis responds favorably to repeat interventions
- Neeraj Jolly, Stephen G Ellis, Irving Franco, Russell E Raymond, Meenakshi Jolly, Jeffrey Hammel, Patrick L Whitlow
- Association of low-density lipoprotein oxidation to abnormal electrocardiographic late potentials
- Pekka Kääpä, Hanna Vihervaara, Markku Ahotupa
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?